Identification of and Structural Insights into Hit Compounds Targeting N-Myristoyltransferase for Cryptosporidium Drug Development

Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors

Plasmodium falciparum NMT substrates are involved in a variety of

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development

Targeting RNA structures with small molecules

Prioritization of Molecular Targets for Antimalarial Drug Discovery

Structure-Based Design of Potent and Selective Leishmania N- Myristoyltransferase Inhibitors

Identification of and Structural Insights into Hit Compounds Targeting N- Myristoyltransferase for Cryptosporidium Drug Development

Structural overlays help to rationalize the SAR for 18 , 19 and 23

Structure of the N-terminal region of ScNMT. A, molecular surface of